Crick African Network to train top African scientists
The Francis Crick Institute and five partner institutes in Africa have today announced a fellowship programme to train African researchers to tackle infectious diseases in their home countries.
Mr South Africa scores a PhD
The current Mr South Africa, Habib Noorbhai, is among the PhD graduates at the mid-year graduation at UCT on 14 July. His research into the backlift technique in cricket - an essential component of a sound batting technique - has underpinned the...
New diploma in cosmetic formulation
Prof Nonhlanhla Khumalo will convene the new diploma that brings cosmetic formulation training under the Division of Dermatology to enhance safe product development for hair and skin.
Novel blindness gene identified
An international consortium that includes UCT geneticists has identified a novel gene, IDH3A, which is implicated in retinitis pigmentosa (RP), an inherited form of blindness.


Friday, 28 July 2017
Support recovery this Mandela Day

The Friends of Valkenberg Trust is calling for donations this Mandela Day to support the recovery of patients at Valkenberg Hospital.

Publication Date:
Thursday, July 13, 2017 - 12:00
Sub-Saharan Africa diabetes threat

As sub-Saharan countries struggle with the current burden of diabetes, new estimates suggest that costs associated with the disease could more than double and may reach up to US$59.3 billion per year by 2030, if type 2 diabetes cases continue to increase. The region is ill-prepared to cope with a growing health burden.

Publication Date:
Wednesday, July 12, 2017 - 09:00
Media statement from the Chairperson of the National Forensic Pathology Services Committee

The statement is endorsed by the head of UCT’s Division of Forensic Medicine Professor Lorna Martin, who is a member of this committee.

Publication Date:
Friday, June 23, 2017 - 15:45
Press Release: World Heart Federation Emerging Leaders to drive improved global access to essential CVD medicines

Access to essential CVD medicines is worryingly low globally and particularly in low- and middle-income countries (LMICs), where some of the barriers to CVD medicines access include poor access to health care facilities, low availability, poor quality of medication and unaffordability.

Publication Date:
Thursday, June 22, 2017 - 09:30